Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP687208.RA7VI2k9-sIzN5XrblXljuP0LBLQcMg3gxUubAEW5tU_o130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP687208.RA7VI2k9-sIzN5XrblXljuP0LBLQcMg3gxUubAEW5tU_o130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP687208.RA7VI2k9-sIzN5XrblXljuP0LBLQcMg3gxUubAEW5tU_o130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP687208.RA7VI2k9-sIzN5XrblXljuP0LBLQcMg3gxUubAEW5tU_o130_provenance.
- NP687208.RA7VI2k9-sIzN5XrblXljuP0LBLQcMg3gxUubAEW5tU_o130_assertion description "[Alemtuzumab is a chimeric CD52 monoclonal antibody with activity in CLL patients with fludarabine-refractory disease and 17p deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687208.RA7VI2k9-sIzN5XrblXljuP0LBLQcMg3gxUubAEW5tU_o130_provenance.
- NP687208.RA7VI2k9-sIzN5XrblXljuP0LBLQcMg3gxUubAEW5tU_o130_assertion evidence source_evidence_literature NP687208.RA7VI2k9-sIzN5XrblXljuP0LBLQcMg3gxUubAEW5tU_o130_provenance.
- NP687208.RA7VI2k9-sIzN5XrblXljuP0LBLQcMg3gxUubAEW5tU_o130_assertion SIO_000772 21670470 NP687208.RA7VI2k9-sIzN5XrblXljuP0LBLQcMg3gxUubAEW5tU_o130_provenance.
- NP687208.RA7VI2k9-sIzN5XrblXljuP0LBLQcMg3gxUubAEW5tU_o130_assertion wasDerivedFrom befree-20140225 NP687208.RA7VI2k9-sIzN5XrblXljuP0LBLQcMg3gxUubAEW5tU_o130_provenance.
- NP687208.RA7VI2k9-sIzN5XrblXljuP0LBLQcMg3gxUubAEW5tU_o130_assertion wasGeneratedBy ECO_0000203 NP687208.RA7VI2k9-sIzN5XrblXljuP0LBLQcMg3gxUubAEW5tU_o130_provenance.
- befree-20140225 importedOn "2014-02-25" NP687208.RA7VI2k9-sIzN5XrblXljuP0LBLQcMg3gxUubAEW5tU_o130_provenance.